Caxton Associates (New York)’s Seres Therapeutics MCRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,108	Closed	-$271K	–	531
2022 Q3	$271K	Sell	2,108 -1,854	-47%	-$238K	0.04%	326
2022 Q2	$272K	Buy	+3,962	New	+$272K	0.03%	390